An observational study in Deep Endometriosis, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by University Hospital, Strasbourg, France · Observational
This retrospective monocentric study aims to assess the feasibility and clinical relevance of three-dimensional (3D) modeling of deep endometriosis lesions derived from pelvic MRI. The study evaluates whether 3D reconstruction improves surgical planning and multidisciplinary management.
901 studies on the registry are indexed under Endometriosis; 259 are open to participants now.
This study's planned enrollment of 60 is below the median of 128 across 344 observational studies indexed under Endometriosis.
Browse Endometriosis studies →University Hospital, Strasbourg, France is the lead sponsor of 968 studies on the registry; 344 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women with surgically managed deep endometriosis and available preoperative pelvic MRI at Strasbourg University Hospital.
Exclusion Criteria:
Impact of 3D modeling on surgical planning
Evaluation of whether 3D reconstruction modifies or confirms the surgical strategy compared to standard MRI interpretation
Time frame: From January 1, 2020 to December 31, 2022
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Strasbourg, France